Uptravi bulk 12 month supply
Ended Awarded Last action
- Contract number
- 36C26024F0353
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $187,680
Award facts
- Contract value 100% obligated
- $187,679.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $1,131 | |
| Original award | $186,549 |
About this award
This federal contract award, valued at $187,679.82, was issued by the Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer. The contract is for the delivery of a 12-month supply of the medication Uptravi, a treatment for pulmonary arterial hypertension.
The contract is a delivery order under Actelion's existing Federal Supply Schedule (FSS-61-IB) contract with the VA, which has a ceiling value of $219,108,390 and runs from August 2024 to July 2029. Actelion also holds two Blanket Purchase Agreements (BPAs) with the VA, valued at $118.5 million and $83.5 million respectively, facilitating streamlined procurement of its specialized pharmaceutical products for veterans and other eligible federal beneficiaries.
This contract award does not utilize any small business set-aside designation, indicating Actelion operates as a large pharmaceutical manufacturer providing critical drug therapies to federal healthcare institutions, including the VA and the Department of Justice Bureau of Prisons.
Quick answers
Who was awarded contract 36C26024F0353?
36C26024F0353 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on July 21, 2024.
How much is contract 36C26024F0353 worth?
The government has obligated $187,680 on 36C26024F0353.
Is contract 36C26024F0353 an order under another contract?
Yes. 36C26024F0353 is a delivery order under 36F79719D0142, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0353 competed?
The extent of competition for 36C26024F0353 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award